Funder: Melanoma Research Alliance
Due Dates (Anticipated): September 2026: Letter of Intent | September 2026: Eligibility checklist & biosketch (Young Investigator) | November 2026: Full proposal (Young Investigator and Pilot Awards) | January 2027: Invited Team Science full proposal | October 2026: RTFCCR-MRA Special Opportunity LOI | February 2027: RTFCCR-MRA Special Opportunity invited full application
Funding Amounts: MRA expects to support at least $11.5 million in new funding across all mechanisms in the cycle; typical Established Investigator Awards are up to $125,000/year for 3 years (total $375,000).
Summary: Supports senior investigators with a proven track record to advance impactful translational research in melanoma prevention, diagnosis, staging, and treatment.
Key Information: All deadlines are projected; confirm on the program page when the new RFP is released.